Articles with "disease still" as a keyword



Photo by dadgrass from unsplash

Repurposing auranofin in nonalcoholic fatty liver disease still requires further evidence.

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical and molecular hepatology"

DOI: 10.3350/cmh.2022.0326

Abstract: and the of nuclear factor kappa B (NF-κB) and inhibitor of NF-κB alpha (IκBα) in LX-2 cells; in HepG2 auranofin erythroid 2-related factor 2 (NRF2) significantly and was required for auranofin to exhibit insulin sensitizing… read more here.

Keywords: nonalcoholic fatty; fatty liver; auranofin nonalcoholic; disease still ... See more keywords